Zobrazeno 1 - 1
of 1
pro vyhledávání: '"William J. Mullally, MBBCh BAO"'
Autor:
James A. Fletcher, M.B.B.S., William J. Mullally, MBBCh BAO, Rahul Ladwa, MPhil, Kenneth J. O’Byrne, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 2, Pp 100591- (2024)
ALK gene rearrangements are detected in approximately 3% to 5% of NSCLC. ALK tyrosine kinase inhibitors, such as third-generation lorlatinib, have exhibited remarkable efficacy in ALK-rearranged NSCLC; however, they have been associated with a low in
Externí odkaz:
https://doaj.org/article/2a5c358e7f60423296225103b8e163b7
